Search results
Results from the WOW.Com Content Network
The now-retracted study included 36 patients with COVID-19, including 20 who were said to have been treated with hydroxychloroquine and azithromycin, an antibiotic.
The medical journal The Lancet on Thursday retracted a large study on the use of hydroxychloroquine to treat COVID-19 because of potential flaws in the research data. Thursday's retraction doesn't ...
Due to safety concerns and evidence of heart arrhythmias leading to higher death rates, the WHO suspended the hydroxychloroquine arm of the Solidarity trial in late May 2020, [14] [15] then reinstated it, [16] then withdrew it again when an interim analysis in June showed that hydroxychloroquine provided no benefit to hospitalized people ...
A French study published in 2024 found that the use of hydroxychloroquine may have been associated with 17,000 deaths in Belgium, Turkey, France, Italy, Spain, and the United States. [61] [62] This study was ultimately retracted on August 22, 2024, after "the Editor-in-Chief found the conclusions of the article to be unreliable".
Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday ...
Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread off-label use of certain drugs as treatments for COVID-19, as president and co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC).
Vladimir "Zev" Zelenko was born to Larisa (Portnoy) Zelenko and Alex in Kyiv, Ukraine (then, part of Soviet Ukraine), on November 27, 1973. [5] [6] His father was a taxi driver and his mother worked at a fur factory before working as a computer programmer at Morgan Stanley. [5]
A new study suggests hydroxychloroquine, which President Donald Trump has endorsed as a potential treatment for COVID-19, does not benefit coronavirus patients who received it. The National ...